Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New agreement between Pharmacopeia and Schering-Plough expands R&D collaboration

Nov. 4, 1998

Aastrom awarded second NIH grant to develop production system for UCB stem cells

Nov. 3, 1998

ArQule, Roche Bioscience amend R&D agreement

Nov. 3, 1998

Targeted Genetics receives patent coverage for cellular therapy platform

Nov. 2, 1998

Senetek licenses autoinjectable drug delivery system to ICN

Oct. 29, 1998

IDEA licenses drug delivery technology to Procter & Gamble

Oct. 28, 1998

CE Mark approval granted for AastromReplicell system components

Oct. 28, 1998

Baxter, Inhale will seek partner to continue development of drug candidate

Oct. 28, 1998

ThromboSol prolongs cryopreservation of rhTPO-stimulated platelets in in vitro study

Oct. 27, 1998

Phase I studies establish feasibility, tolerability of oral delivery of heparin

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...